Babatunde Adebola Alabi

Dr. Babatunde Adebola Alabi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
BABabatunde Adebola Alabi
Babatunde Adebola Alabi
OAOnyemaechi Azu
Onyemaechi Azu
ZDZodwa Dlamini
Zodwa Dlamini
RKRichard Khanyile
Richard Khanyile
RMRahaba Marima
Rahaba Marima
Human exposure to micro- and nanoplastics (MP/NPs) is increasingly recognized as a potential environmental health concern, although their role in reproductive carcinogenesis remains unclear. This narrative review aims to evaluate current evidence linking MP/NP exposure to reproductive cancers and to explore the potential chemoprotective effects of bioactive compounds derived from ginger, garlic, and turmeric. A structured literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar for studies published between 2008 and 2026. Relevant in vitro, in vivo, and human biomonitoring studies were included to assess mechanisms of toxicity, while preclinical and clinical studies were reviewed to examine the anticancer properties of selected dietary phytochemicals. Available evidence suggests that MP/NPs can accumulate in human biological systems, including reproductive tissues, where they induce oxidative stress, chronic inflammation, endocrine disruption, and DNA damage, processes closely associated with carcinogenesis. Although epidemiological data remain limited and do not establish cancer, emerging biomonitoring and experimental findings support a biologically plausible link between MP/NP exposure and hormone-related cancers. Concurrently, bioactive compounds such as curcuminoids, gingerols, and organosulfur compounds demonstrate the ability to modulate key molecular pathways involved in oxidative stress, inflammation, and cell proliferation. Preclinical studies consistently report anticancer effects, while early clinical evidence suggests improvements in oxidative and inflammatory biomarkers, though definitive therapeutic benefits remain uncertain. Overall, this review highlights important mechanistic links and identifies dietary phytochemicals as potential modulators of MP/NP-induced carcinogenic pathways. However, further well-designed epidemiological and clinical studies are needed to clarify causal relationships and validate their protective role.

24 February 2026 in Onco
Verified
Journal Article
Open access
PDF file
JMJessica McIntyre
Jessica McIntyre
RMRahaba Marima
Rahaba Marima
BABabatunde Adebola Alabi
Babatunde Adebola Alabi
GRGopika Devi Ramkilawon
Gopika Devi Ramkilawon
BMBenny Mosoane
Benny Mosoane
Background: Cervical cancer is the second most prevalent malignancy among South African women, with high-risk human papillomavirus (HPV) infection as a critical risk factor. HPV plays a central role in cervical carcinogenesis, particularly in high-grade squamous intraepithelial lesions (HSIL). Increased programmed death ligand 1 (PD-L1) expression has been implicated in cervical carcinoma tumorigenesis. Using immunohistochemistry, this study investigated the correlation between high-risk HPV-driven cervical intraepithelial neoplasia (CIN) and PD-L1 expression. Methods: An analytical cross-sectional study was conducted on archival tissue from the Department of Anatomical Pathology, University of Pretoria (2018–2021). Formalin-fixed paraffin-embedded tissues from loop electrosurgical excisions, cone biopsies, punch biopsies, and polypectomies were analysed. PD-L1 expression was assessed using the combined proportion score (CPS). Three pathologists independently evaluated histological grade, p16 immunohistochemistry, and PD-L1 expression. Results: Among 108 cases (mean age: 37.36 years), 89.8% were CIN 3, 9.3% CIN 2, and 0.9% CIN 2–3. p16 was positive in 97.2% of cases. PD-L1 expression (CPS ≥ 1) was observed in 9.3% of cases, with a mean CPS of 1.57%. No significant association was found between PD-L1 expression and CIN grade (p = 0.6433, Cramer’s V = 0.1191) or between PD-L1 and p16 positivity (p = 1, Cramer’s V = 0.05976). Conclusions: This study demonstrates no correlation between PD-L1 expression and high-risk HPV-driven high-grade CIN. These findings suggest that immune checkpoint inhibition targeting PD-L1 may have limited therapeutic relevance in HSIL among South African women.

1 June 2026 in Epigenomes
Verified
Journal Article
Open access
PDF file
OFOLALEKAN OLATUNDE FADEBI
OLALEKAN OLATUNDE FADEBI
BABabatunde Adebola Alabi
Babatunde Adebola Alabi
RKRichard Khanyile
Richard Khanyile
ZDZodwa Dlamini
Zodwa Dlamini
RMRahaba Marima
Rahaba Marima
Background: Triple-negative breast cancer (TNBC) remains a clinical challenge due to its aggressive nature and the frequent emergence of therapeutic resistance. While the role of protein-coding genes in DNA repair is well-documented, the regulatory contributions of the non-coding genome, specifically long intergenic non-coding RNAs (lincRNAs), remain largely undefined. Objectives: In this study, we characterize the biological significance of LincRNA-BC7, a novel transcript identified within the breast cancer field effect. Methods: Through a combined in silico and in vitro approach, we investigated the transcriptional dynamics of the LincRNA-BC7/miR-663a/BRCA1 axis in response to the PARP inhibitor, Olaparib. Results: Our results demonstrate that Olaparib induces selective cytotoxicity in BRCA1-deficient MDA-MB-231 cells while sparing non-cancerous HEK293 cells, a response accompanied by a significant downregulation of LincRNA-BC7 and a reciprocal upregulation of BRCA1. Bioinformatics analysis through BLASTN, miRBase, and KEGG revealed that LincRNA-BC7 contains highly complementary binding sites for miR-663a, suggesting it functions as a competing endogenous RNA (ceRNA) or “molecular sponge.” Conclusions: By sequestering miR-663a, LincRNA-BC7 appears to modulate the expression of critical signaling nodes within the PI3K-AKT and TP53 pathways, thereby influencing cellular sensitivity to DNA-damaging agents. These findings suggest that LincRNA-BC7 is a key determinant of the aggressive TNBC phenotype and the response to PARP inhibition. Our study establishes the LincRNA-BC7/miR-663a axis as a novel biomarker for precision risk stratification and a promising therapeutic target to enhance treatment outcomes in BRCA1-associated breast cancers.

Verified
Journal Article
Open access
PDF file
ANAmahle Nyalambisa
Amahle Nyalambisa
BABabatunde Adebola Alabi
Babatunde Adebola Alabi
ZDZodwa Dlamini
Zodwa Dlamini
RMRahaba Marima
Rahaba Marima
Cervical cancer (CCa) is the fourth leading cause of cancer-related deaths among women worldwide, with nearly 90% of cases in low- and middle-income countries, especially in Sub-Saharan Africa. This study explores the roles of circular ribonucleic acids (circRNAs), hsa_circ_0001038 and circRNA_400029, and the impact of the serine/arginine-rich splicing factor 3 (SRSF3) inhibitor, theophylline, in CCa cell lines. We utilized cell cycle fluorescence-activated cell sorting (FACS) and Annexin V/propidium iodide (PI) assays to evaluate theophylline’s effects on SiHa and C33A cell lines. Results showed S-phase arrest in SiHa and G2/M arrest in C33A, with significant cytotoxic effects indicated by apoptosis analysis. Using CircAtlas, we identified micro ribonucleic acids (miRNAs) binding to hsa_circ_0001038, particularly miR-205-5p, which has a tumour-suppressive role. miRTarBase identified miR-16-5p as a key interacting miRNA for circRNA_400029. We constructed a competing endogenous ribonucleic acid (ceRNA) network, revealing multiple miRNA targets. Pathway analysis via the Kyoto Encyclopedia of Genes and Genomes (KEGG) highlighted critical signalling pathways involved in CCa oncogenesis. In conclusion, theophylline demonstrates cytotoxicity in CCa cells, suggesting its potential for repurposing in CCa theranostics, though further optimization is necessary.